2012如何认识调脂药物的调脂外作用
万方数据
万方数据
万方数据
如何认识调脂药物的调脂外作用
作者:李建军
作者单位:中国医学科学院阜外心血管病医院国家心血管病中心国家心血管病重点实验室血脂异常与心血管疾病诊治中心,北京,100037
刊名:
中国医学前沿杂志(电子版)
英文刊名:Chinese Journal of the Frontiers of Medical Science(Electronic Version)
年,卷(期):2012,04(8)
被引用次数:4次
参考文献(11条)
1.Li JJ Early,intensive and long-term statin therapy in acute coronary syndrome:focus on an anti-inflammatory mechanism 2005(03)
2.Fang CH;Li JJ Statin,like aspirin,should be given as early as possible in patients with acute coronary syndrome 2004
3.Li JJ;Lu ZL;kou WR Impact of long-term Xuezhikang therapy on cardiovascular events in high-risk patients with nonspecific,preexisting kiver tests:a post-hoc analysis from Chinese Coronary Secondary Prevention Study (CCSPS) 2012
4.Guo YL;Liu J;Li JJ A multi-center survey of achieving recommended lipidgoals in Chinese patients with coronary artery disease in real world cardiovascularpractice 2011
5.Bonetti PO;Lerman LO;Napoli C Statin effects beyond lipid lowering-are they clinically relevant 2003
6.Feldman LS;Brotman DJ Perioperative statins:more than lipid-lowering 2008
7.W(a)gner AM;Sánchez-Quesada JL;Benítez S Effects of statin and fibrate treatment on inflammation in type 2 diabetes.A randomized,cross-over study 2011(01)
8.Florentin M;Liberopoulos EN;Kei A Pleiotropic effects of nicotinic acid:beyond high density lipoprotein cholesterol elevation 2011
9.Ljioma N;Robinson JG Lipid-lowering effects of ezetimibe and simvastatin in combination 2011
10.Wang HR;Li JJ;Huang CX Fluvastatin inhibits the expression of tumor necrosis factor-a and activation of nuclear factor-kB in endothelial cells stimulated by C-reactive protein 2005
11.Li J;Li JJ;He JG Inhibition of atorvaststin on C-reactive protein-induced inflammatory response in pulmonary artery smooth muscle cell by nuclear factor-κB pathway 2010
引证文献(3条)
1.席振创(综述),王志蕴(审校)他汀类药物调脂外效应研究进展[期刊论文]-现代医药卫生 2014(21)
2.卢熠,杨悦降血脂药物的临床应用与展望[期刊论文]-中国当代医药 2014(05)
3.温涛,贾永平,张巧玲,索云飞,王雪涛,王吉军阿托伐他汀联用依折麦布对冠心病的治疗效果评价[期刊论文]-中西医结合心脑血管病杂志 2013(11)
引用本文格式:李建军如何认识调脂药物的调脂外作用[期刊论文]-中国医学前沿杂志(电子版) 2012(8)